
Laura Lynne Stockton
Examiner (ID: 15659, Phone: (571)272-0710 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1201, 2899, 1626, 1613, 1614, 1646 |
| Total Applications | 3283 |
| Issued Applications | 2225 |
| Pending Applications | 331 |
| Abandoned Applications | 760 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16955969
[patent_doc_number] => 11059809
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-13
[patent_title] => Substituted cyanopyrrolidines with activity as DUB inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/615709
[patent_app_country] => US
[patent_app_date] => 2018-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11719
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 216
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16615709
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/615709 | Substituted cyanopyrrolidines with activity as DUB inhibitors | Jun 18, 2018 | Issued |
Array
(
[id] => 14198825
[patent_doc_number] => 10266505
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-23
[patent_title] => Compositions and methods for treating cancers
[patent_app_type] => utility
[patent_app_number] => 16/012536
[patent_app_country] => US
[patent_app_date] => 2018-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 25
[patent_no_of_words] => 29516
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16012536
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/012536 | Compositions and methods for treating cancers | Jun 18, 2018 | Issued |
Array
(
[id] => 16839428
[patent_doc_number] => 20210147440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => METHODS FOR THE PREPARATION OF 1,3-BENZODIOXOLE HETEROCYCLIC COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/624491
[patent_app_country] => US
[patent_app_date] => 2018-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9096
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16624491
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/624491 | Methods for the preparation of 1,3-benzodioxole heterocyclic compounds | Jun 18, 2018 | Issued |
Array
(
[id] => 13621959
[patent_doc_number] => 20180362531
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-20
[patent_title] => NOVEL KYNUREININE PATHWAY INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/011432
[patent_app_country] => US
[patent_app_date] => 2018-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6384
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16011432
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/011432 | NOVEL KYNUREININE PATHWAY INHIBITORS | Jun 17, 2018 | Abandoned |
Array
(
[id] => 13589815
[patent_doc_number] => 20180346456
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => SMALL MOLECULE AGONISTS AND ANTAGONISTS OF NR2F6 ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 16/008526
[patent_app_country] => US
[patent_app_date] => 2018-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23302
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16008526
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/008526 | Small molecule agonists and antagonists of NR2F6 activity | Jun 13, 2018 | Issued |
Array
(
[id] => 13478895
[patent_doc_number] => 20180290990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-11
[patent_title] => DESFERRITHIOCIN POLYETHER ANALOGUES
[patent_app_type] => utility
[patent_app_number] => 16/005483
[patent_app_country] => US
[patent_app_date] => 2018-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7761
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16005483
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/005483 | DESFERRITHIOCIN POLYETHER ANALOGUES | Jun 10, 2018 | Abandoned |
Array
(
[id] => 13478985
[patent_doc_number] => 20180291035
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-11
[patent_title] => MYC MODULATORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/005455
[patent_app_country] => US
[patent_app_date] => 2018-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35995
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -88
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16005455
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/005455 | MYC MODULATORS AND USES THEREOF | Jun 10, 2018 | Abandoned |
Array
(
[id] => 13478985
[patent_doc_number] => 20180291035
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-11
[patent_title] => MYC MODULATORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/005455
[patent_app_country] => US
[patent_app_date] => 2018-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35995
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -88
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16005455
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/005455 | MYC MODULATORS AND USES THEREOF | Jun 10, 2018 | Abandoned |
Array
(
[id] => 13440601
[patent_doc_number] => 20180271843
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-27
[patent_title] => HISTONE DEMETHYLASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 15/996316
[patent_app_country] => US
[patent_app_date] => 2018-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14589
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15996316
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/996316 | Histone demethylase inhibitors | May 31, 2018 | Issued |
Array
(
[id] => 13589795
[patent_doc_number] => 20180346446
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => IRE1 SMALL MOLECULE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 15/994901
[patent_app_country] => US
[patent_app_date] => 2018-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39935
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15994901
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/994901 | IRE1 SMALL MOLECULE INHIBITORS | May 30, 2018 | Abandoned |
Array
(
[id] => 15070945
[patent_doc_number] => 10464948
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-05
[patent_title] => Polycyclic diiminooxadiazinones
[patent_app_type] => utility
[patent_app_number] => 15/989288
[patent_app_country] => US
[patent_app_date] => 2018-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4585
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15989288
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/989288 | Polycyclic diiminooxadiazinones | May 24, 2018 | Issued |
Array
(
[id] => 19491590
[patent_doc_number] => 12110286
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-08
[patent_title] => Benzimidazolone derived inhibitors of BCL6
[patent_app_type] => utility
[patent_app_number] => 16/616901
[patent_app_country] => US
[patent_app_date] => 2018-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 76547
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 243
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16616901
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/616901 | Benzimidazolone derived inhibitors of BCL6 | May 24, 2018 | Issued |
Array
(
[id] => 16177122
[patent_doc_number] => 20200224090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => ORGANIC LUMINOGENS
[patent_app_type] => utility
[patent_app_number] => 16/615667
[patent_app_country] => US
[patent_app_date] => 2018-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10603
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16615667
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/615667 | Organic luminogens | May 23, 2018 | Issued |
Array
(
[id] => 17060061
[patent_doc_number] => 11104648
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-31
[patent_title] => Pyrazole derivative
[patent_app_type] => utility
[patent_app_number] => 16/620814
[patent_app_country] => US
[patent_app_date] => 2018-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 25168
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16620814
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/620814 | Pyrazole derivative | May 21, 2018 | Issued |
Array
(
[id] => 16854898
[patent_doc_number] => 20210155643
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-27
[patent_title] => DEUTERATED PYRIDONE AMIDES AND PRODRUGS THEREOF AS MODULATORS OF SODIUM CHANNELS
[patent_app_type] => utility
[patent_app_number] => 16/614015
[patent_app_country] => US
[patent_app_date] => 2018-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17288
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16614015
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/614015 | Deuterated pyridone amides and prodrugs thereof as modulators of sodium channels | May 15, 2018 | Issued |
Array
(
[id] => 15930915
[patent_doc_number] => 20200157091
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => PYRROLO[2,3-C]PYRIDINES AND RELATED ANALOGS AS LSD-1 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/611238
[patent_app_country] => US
[patent_app_date] => 2018-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23740
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16611238
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/611238 | Pyrrolo[2,3-C]pyridines and related analogs as LSD-1 inhibitors | May 14, 2018 | Issued |
Array
(
[id] => 15962957
[patent_doc_number] => 20200165230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-28
[patent_title] => 3,4,5-Trisubstituted-1,2,4-Triazoles and 3,4,5-Trisubstituted-3-Thio-1,2,4-Triazoles and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 16/613086
[patent_app_country] => US
[patent_app_date] => 2018-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39608
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -59
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16613086
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/613086 | 3,4,5-trisubstituted-1,2,4-triazoles and 3,4,5-trisubstituted-3-thio-1,2,4-triazoles and uses thereof | May 10, 2018 | Issued |
Array
(
[id] => 13386247
[patent_doc_number] => 20180244665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-30
[patent_title] => XANTHINE OXIDASE INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 15/968227
[patent_app_country] => US
[patent_app_date] => 2018-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20188
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 233
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15968227
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/968227 | Xanthine oxidase inhibitor | Apr 30, 2018 | Issued |
Array
(
[id] => 13521929
[patent_doc_number] => 20180312507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-01
[patent_title] => FUSED INDAZOLE PYRIDONE COMPOUNDS AS ANTIVIRALS
[patent_app_type] => utility
[patent_app_number] => 15/965172
[patent_app_country] => US
[patent_app_date] => 2018-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41975
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 524
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15965172
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/965172 | Fused indazole pyridone compounds as antivirals | Apr 26, 2018 | Issued |
Array
(
[id] => 13386245
[patent_doc_number] => 20180244664
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-30
[patent_title] => PYRAZOL-3-ONES THAT ACTIVATE PRO-APOPTOTIC BAX
[patent_app_type] => utility
[patent_app_number] => 15/963858
[patent_app_country] => US
[patent_app_date] => 2018-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24270
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15963858
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/963858 | Pyrazol-3-ones that activate pro-apoptotic BAX | Apr 25, 2018 | Issued |